Clinical trials
Observational Mesothelioma, Malignant trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2013 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Recruiting | 2 |
| Withdrawn | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| A2 Biotherapeutics Inc. | 1 |
| Barbara Ann Karmanos Cancer Institute | 1 |
| Case Comprehensive Cancer Center | 1 |
| Gynecologic Oncology Group | 1 |
| Henry Ford Health System | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| National Cancer Institute (NCI) | 1 |
| ProgenaBiome | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mesothelioma, Malignant | 8 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Carcinoma, Renal Cell | 2 |
| Lung Neoplasms | 2 |
| Mesothelioma | 2 |
| Neoplasms | 2 |
| Ovarian Neoplasms | 2 |
| Brenner Tumor | 1 |
| Cholangiocarcinoma | 1 |
| Colorectal Neoplasms | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.